HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xishi Liu Selected Research

Prokaryotic Initiation Factor-3

1/2019The Possible Role of Eukaryotic Translation Initiation Factor 3 Subunit e (eIF3e) in the Epithelial-Mesenchymal Transition in Adenomyosis.
1/2018Reduced Expression of Eukaryotic Translation Initiation Factor 3 Subunit e and Its Possible Involvement in the Epithelial-Mesenchymal Transition in Endometriosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xishi Liu Research Topics

Disease

52Endometriosis
06/2022 - 01/2008
24Hyperalgesia
05/2022 - 04/2010
24Adenomyosis
05/2022 - 01/2008
22Fibrosis (Cirrhosis)
01/2022 - 01/2016
10Pain (Aches)
11/2019 - 04/2010
8Neoplasms (Cancer)
05/2021 - 08/2009
6Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2021 - 07/2010
5Dysmenorrhea (Menstrual Pain)
01/2022 - 01/2008
3Inflammation (Inflammations)
06/2022 - 10/2012
3Metaplasia
01/2019 - 04/2016
3Body Weight (Weight, Body)
10/2017 - 04/2012
3Carcinoma (Carcinomatosis)
04/2015 - 07/2010
3Endometrial Neoplasms (Endometrial Cancer)
04/2013 - 06/2007
2Neoplasm Metastasis (Metastasis)
01/2016 - 01/2015
2Hemorrhage
07/2015 - 02/2011
2Leiomyoma (Uterine Fibroids)
01/2015 - 09/2014
1Hyperprolactinemia
03/2022
1Hypoxia (Hypoxemia)
01/2022
1Infections
05/2021

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
02/2021 - 08/2009
11Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2008
8Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 06/2007
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021 - 03/2013
6TamoxifenFDA LinkGeneric
04/2017 - 07/2011
5Estrogens (Estrogen)FDA Link
03/2022 - 04/2014
5Adrenergic Agents (Adrenergic Drugs)IBA
01/2020 - 01/2016
5CollagenIBA
01/2019 - 07/2014
4Therapeutic UsesIBA
06/2022 - 08/2013
4Cadherins (E-Cadherin)IBA
09/2021 - 02/2017
4salicylhydroxamic acid (SHAM)IBA
01/2019 - 04/2010
4Valproic Acid (Depakote)FDA LinkGeneric
04/2012 - 01/2008
3Progestins (Progestagens)IBA
03/2022 - 02/2011
3Dinoprostone (PGE2)FDA Link
01/2022 - 01/2022
3NeuropeptidesIBA
02/2021 - 01/2019
3Adrenergic Receptors (Adrenergic Receptor)IBA
06/2020 - 11/2016
3Lysine (L-Lysine)FDA Link
01/2017 - 03/2014
3SolventsIBA
10/2016 - 12/2013
3CorticosteroneIBA
10/2016 - 12/2013
3ThrombinFDA Link
01/2016 - 01/2015
3Thromboplastin (Tissue Factor)IBA
04/2015 - 02/2011
3Oxytocin Receptors (Oxytocin Receptor)IBA
07/2014 - 04/2010
3Protein Isoforms (Isoforms)IBA
07/2014 - 11/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2013 - 04/2010
3andrographolideIBA
08/2013 - 05/2012
3theasinensin AIBA
01/2013 - 06/2007
3NF-kappa B (NF-kB)IBA
01/2011 - 11/2008
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2022 - 02/2021
2Substance PIBA
02/2021 - 01/2019
2Calcitonin Receptor-Like ProteinIBA
02/2021 - 01/2019
2Receptor Activity-Modifying Protein 1IBA
02/2021 - 01/2019
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
11/2020 - 01/2019
2Aprepitant (Emend)FDA Link
11/2020 - 01/2019
2Propranolol (Inderal)FDA LinkGeneric
11/2020 - 11/2016
2AntibodiesIBA
11/2020 - 04/2015
2DesminIBA
01/2020 - 02/2017
2Prokaryotic Initiation Factor-3IBA
01/2019 - 01/2018
2Pharmaceutical PreparationsIBA
10/2017 - 07/2011
2Thromboxane A2 (A2, Thromboxane)IBA
01/2017 - 01/2016
2Histones (Histone)IBA
01/2017 - 01/2012
2Carrier Proteins (Binding Protein)IBA
11/2016 - 01/2016
2ElementsIBA
11/2016 - 01/2016
2Phosphates (Orthophosphate)IBA
11/2016 - 01/2015
2Immunoglobulin G (IgG)IBA
10/2016 - 04/2015
2ozagrelIBA
10/2016 - 10/2016
2Tranylcypromine (Parnate)FDA LinkGeneric
04/2016 - 03/2014
2Transforming Growth Factors (Transforming Growth Factor)IBA
04/2016 - 02/2016
2Estrogen ReceptorsIBA
01/2015 - 01/2015
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
07/2014 - 12/2013
2Transcription Factors (Transcription Factor)IBA
04/2014 - 08/2013
2trichostatin A (A 300)IBA
01/2013 - 04/2010
2Histone Deacetylase InhibitorsIBA
04/2012 - 04/2010
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2022
1ProlactinIBA
03/2022
1Metformin (Glucophage)FDA LinkGeneric
01/2022
1Hormones (Hormone)IBA
01/2022
1Hemoglobins (Hemoglobin)IBA
05/2021
1EnzymesIBA
05/2021
1ImmunosorbentsIBA
05/2021
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
02/2021
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
02/2021
1Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
02/2021
1Calbindin 2IBA
11/2020
1SurvivinIBA
09/2020
1P-2 (P 2)IBA
09/2020
1tanshinone II A sodium sulfonateIBA
09/2020
1Hyaluronan SynthasesIBA
09/2020
1GalactosidasesIBA
09/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2020
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
06/2020

Therapy/Procedure

20Therapeutics
01/2022 - 07/2010
6Hysterectomy
08/2019 - 07/2010
5Intraperitoneal Injections
06/2020 - 04/2015
3Drug Therapy (Chemotherapy)
05/2021 - 09/2015
3Laparotomy
01/2016 - 07/2010
2Vagus Nerve Stimulation
06/2022 - 01/2021
2Vagotomy
06/2022 - 01/2021
2Radiotherapy
05/2021 - 04/2013
2Transplantation
04/2015 - 04/2015
1Electrocoagulation (Electrocautery)
11/2020